SPECT Equipment Market Size, Share & Opportunities by 2034
SPECT Equipment Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type [Hybrid SPECT (SPECT-MR and SPECT- CT) and Standalone SPECT], Radioisotope Type (Iodine-123, Technetium-99m, Xenon-133, Thallium-201, Radium-223, Gallium-66, and Others), Application (Seizures, Stroke, Stress Fractures, Infections, Tumors, and Others), and End User (Hospitals, Imaging Centers, and Others)
- Status : Data Released
- Report Code : TIPRE00026136
- Category : Life Sciences
- No. of Pages : 150
- Available Report Formats :
The global SPECT equipment market size is expected to reach US$ 2.77 billion by 2034 from US$ 1.85 billion in 2025. The market is anticipated to register a CAGR of 4.59% during 2026–2034.
SPECT Equipment Market AnalysisThe SPECT equipment market is experiencing a significant transition from traditional qualitative imaging to precision quantitative molecular diagnostics. To remain competitive, vendors are required to shift from offering standalone hardware to offering integrated Cardiovascular-Renal-Metabolic (CVRM) and cancer diagnostic platforms. One important opportunity is using Cadmium Zinc Telluride (CZT) solid-state detectors, which improve spatial resolution and reduce scan times. These changes are important for helping more patients and reducing radioisotope waste. Manufacturers should also update their hybrid SPECT/CT products to match the rising Theranostics trend, where SPECT is used as a key tool to check doses for targeted alpha and beta therapies. Success in the next decade will be defined by the ability to provide AI-augmented reconstruction software that compensates for low-count statistics, thereby enabling lower patient radiation doses while maintaining diagnostic integrity across diverse clinical networks.
SPECT Equipment Market OverviewThe SPECT equipment market represents a specialized segment within nuclear medicine imaging, employing gamma-emitting radiopharmaceuticals to visualize physiological processes. These systems, including both hybrid SPECT/CT and standalone units, form the basis for functional imaging uses such as myocardial perfusion, bone scans, and neuro-functional assessments. The market is undergoing a significant transformation as more diagnostic workflows become digital and hybrid systems that combine anatomical and functional data are used more often. In the past, supply chain issues with Technetium-99m caused instability; the market is becoming more stable due to regional radiopharmacy networks and new ways to produce isotopes without generators. This sector serves a critical role in global healthcare by enabling non-invasive early detection of diseases, thereby reducing the long-term clinical and financial burden on hospital systems and outpatient imaging centers.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
SPECT Equipment Market: Strategic Insights
| Market Size Value in | US$ 1,552.02 million in 2021 |
| Market Size Value by | US$ 2,109.05 million by 2028 |
| Growth rate | CAGR of 4.5% from 2021 to 2028. |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
- Rising Demand for Operational Efficiency in Nuclear Medicine: Healthcare organizations are experiencing higher patient volumes and elevated operational costs due to isotope decay. As a result, there is a growing demand for SPECT/CT systems equipped with high-speed CZT detectors to ensure high throughput and clinical accuracy.
- Advancements in Hybrid Imaging and Protocol Standardization: The worldwide shift to SPECT/CT has broadened nuclear medicine use in clinics. Adding CT for attenuation correction and anatomical localization is now standard in oncology and cardiology, not just an extra feature.
- Expanding Radiopharmaceutical Portfolios and Isotope Stability: Government-led initiatives to stabilize the Technetium-99m supply chain and the approval of novel tracers for neurology and infection are driving the widespread implementation of SPECT IT solutions and hardware updates.
Market Opportunities:
- Expansion into Emerging Markets with Growing Diagnostic Sectors: Countries such as China, India, and Brazil are seeing increased adoption of SPECT systems. This growth is driven by substantial investments in nuclear medicine infrastructure and the rise of private oncology centers.
- Integration with AI-Driven Quantitative Analytics: Pairing SPECT hardware with advanced AI analytics makes data management smoother. Machine learning also helps clinicians make clearer decisions when monitoring therapy, especially when tracking how bone metastases respond to treatment.
- Demand for Theranostics-Ready Infrastructure: The trend toward precision medicine is a main driver for specialized SPECT systems. These units enable the visualization of "target" uptake before radiotherapy, contributing to the improvement of personalized healthcare delivery.
The SPECT equipment market share is analyzed across various segments to provide a clearer understanding of its structure, growth potential, and emerging trends. Below is the standard segmentation approach used in most industry reports:
By Type:
- Hybrid SPECT
- Standalone SPECT
By Radioisotope Type:
- Iodine-123
- Technetium-99m
- Xenon-133
- Thalium-201
- Radium-223
- Gallium-66
By Application:
- Seizures
- Stroke
- Stress Fractures
- Infections
- Tumors
By End User:
- Hospitals
- Imaging Centers
By Geography:
- North America
- Europe
- Asia Pacific
- South & Central America
- Middle East & Africa
Market Report Scope
SPECT Equipment Market Share Analysis by GeographyAsia Pacific is expected to grow fastest in the coming years. Emerging markets in South & Central America, the Middle East, and Africa also have many untapped opportunities for diagnostic imaging providers to expand.
The SPECT equipment market shows a different growth trajectory in each region due to factors such as healthcare infrastructure, nuclear medicine maturity, regulatory environments, and the establishment of radiopharmaceutical networks. Below is a summary of market share and trends by region:
1. North America
- Market Share: Holds the largest market share due to advanced nuclear medicine networks and early adoption of hybrid technology.
- Key Drivers:
- Strong presence of innovators like GE HealthCare, Cardinal Health, and Lantheus
- Favorable reimbursement for myocardial perfusion imaging (MPI)
- High demand for advanced Revenue Cycle Management (RCM) tools in diagnostics
- Trends: Shift toward cloud-based image processing and AI-aided dose optimization to enhance patient safety and workflow efficiency in high-volume imaging centers.
2. Europe
- Market Share: Significant share driven by strict diagnostic governance and national health initiatives.
- Key Drivers:
- Mandatory regulatory compliance and adherence to EMA safety standards
- High uptake of hybrid SPECT/CT for complex neurology and oncology cases
- Strong government support for "Chemicals Strategy for Sustainability" affects radiotracer production
- Trends: Increasing use of interoperable platforms to support cross-border health data exchange and unified care delivery in nuclear medicine across the EU.
3. Asia Pacific
- Market Share: Fastest-growing region owing to rapid urbanization and government-led digital health missions in China and India.
- Key Drivers:
- Rapid expansion of biomanufacturing and new radiopharmacy establishments
- Surge in private specialty hospitals and diagnostic centers
- Rising prevalence of cardiovascular and oncology-related patient volumes
- Trends: Adoption of AI-driven SPECT systems for faster patient throughput and automated lesion detection, catering to the massive patient demand in urban healthcare hubs.
4. South and Central America
- Market Share: Emerging market with growing adoption of minimally invasive diagnostic tools and hybrid systems.
- Key Drivers:
- Modernization of oncology and cardiology centers in Brazil and Mexico
- Rising demand for cost-effective nuclear imaging compared to PET/CT
- Expansion of private health insurance coverage for advanced diagnostics
- Trends: Increasing penetration of global medical imaging brands alongside the development of regional radiopharmaceutical production to stabilize the isotope supply chain.
5. Middle East and Africa
- Market Share: Developing market with high growth potential driven by heavy investments in healthcare infrastructure.
- Key Drivers:
- National "Smart Hospital" initiatives and e-health strategies in GCC countries
- Establishment of new precision-medicine clusters focusing on molecular diagnostics
- High demand for medical practice automation in integrated care models
- Trends: Implementation of specialized SPECT/CT systems in newly built oncology centers and medical cities as part of broader national health transformation programs.
High Market Density and Competition
Competition is intensifying due to the presence of major vendors such as GE HealthCare Technologies Inc., Siemens Healthineers, and Philips Healthcare. Regional and specialized players like Mediso Ltd (Hungary) and MiE GmbH (Germany) also contribute to the crowded and technologically sophisticated market landscape.
This competitive environment pushes vendors to differentiate through:
- Hybrid Imaging Modalities: Integrating SPECT with Computed Tomography (CT) or Magnetic Resonance (EMR) on a single gantry to provide superior anatomical localization alongside functional data.
- Solid-State Detector Technology: Transitioning from traditional sodium iodide crystals to Cadmium-Zinc-Telluride (CZT) detectors to achieve higher spatial resolution and faster image acquisition.
- AI-Powered Image Reconstruction: Utilizing artificial intelligence and machine learning algorithms to reduce noise, shorten scan times, and lower the necessary radiopharmaceutical dose for patients.
- Theranostic Support Capabilities: Designing equipment that supports the growing "theranostics" trend, allowing for precise treatment monitoring and personalized dosimetry in oncology and cardiology.
Opportunities and Strategic Moves
- Partner with radiopharmaceutical suppliers and research institutes to support the development of next-generation tracers, ensuring equipment compatibility with emerging diagnostic and therapeutic agents.
- Incorporate cloud-based informatics and digital workflow solutions to streamline data management across hospital networks and diagnostic imaging centers.
- Cardinal Health, Inc. – United States
- Curium – France
- Lantheus Medical Imaging, Inc. – United States
- Mediso Ltd – Hungary
- NTP Radioisotopes – South Africa
- Bracco Imaging S.p.A. – Italy
- Star Equity Holdings, Inc. – United States
- Bruker Corporation – United States
- MiE GmbH – Germany
Disclaimer: The companies listed above are not ranked in any particular order.
SPECT Equipment Market News and Recent Developments- In May 2025, GE HealthCare received FDA 510(k) clearance for its Aurora dual-head SPECT/CT system with AI-powered Clarify DL deep learning reconstruction technology. The system enhances image quality and scan efficiency, supporting adoption in hospitals and diagnostic centers.
- In January 2024, Siemens Healthineers received FDA clearance for syngo Virtual Cockpit, the first multi-vendor remote scanning software supporting SPECT, SPECT/CT, and other imaging modalities. The technology enables real-time remote scanning and support across multiple scanners, addressing technologist shortages and improving operational efficiency, thereby supporting adoption and utilization in the SPECT equipment market.
The "SPECT Equipment Market Size and Forecast (2021–2034)" report provides a detailed analysis of the market covering below areas:
- SPECT Equipment Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- SPECT Equipment Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- SPECT Equipment Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the SPECT Equipment Market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Radioisotope Type, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Major players include GE HealthCare Technologies, Siemens Healthineers, Philips Healthcare, Cardinal Health, Lantheus Medical Imaging, Mediso Ltd, and Bracco Imaging.
North America holds the largest share, while Asia Pacific is the fastest-growing region, with emerging opportunities in South & Central America, and the Middle East & Africa.
The market covers both hybrid SPECT/CT systems and standalone SPECT systems that are used in nuclear medicine imaging.
Growth is mainly driven by a greater need for operational efficiency, advances in hybrid imaging, and more reliable radiopharmaceutical supply chains.
The market is expected to grow from US$ 1.85 billion in 2025 to US$ 2.77 billion by 2034, registering a CAGR of 4.59% during 2026–2034.
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For